The ovarian response to controlled stimulation in IVF cycles may be predictive of the age at menopause

Human Reproduction

Volumn 29, Issue 11, 2014, Pages 2530-2535

  La Marca, A ^a   Dondi, G ^a   Sighinolfi, G ^a   Giulini, S ^a   Papaleo, E ^b   Cagnacci, A ^a   Faddy, M J ^c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

menopause prediction; oocytes; ovarian reserve

Indexed keywords

GONADOTROPIN;

ADULT; AGE DISTRIBUTION; ARTICLE; CROSS-SECTIONAL STUDY; DEMOGRAPHY; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MENOPAUSE; OOCYTE RETRIEVAL; OVARIAN RESERVE; OVARY FUNCTION; POPULATION; AGE; DRUG EFFECTS; OVARY; OVULATION INDUCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREDICTIVE VALUE; PROCEDURES;

AGE FACTORS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFERTILITY, FEMALE; MENOPAUSE; OVARY; OVULATION INDUCTION; PREDICTIVE VALUE OF TESTS;

EID: 84913554519     PISSN: 02681161     EISSN: 14602350     Source Type: Journal    
DOI: 10.1093/humrep/deu234     Document Type: Article

References (43)

1. Broekmans FJ, Faddy MJ, Scheffer G, te Velde ER. Antral follicle counts are related to age at natural fertility loss and age at menopause. Menopause 2004;11:607-614.
2. Broekmans FJ, Soules MR, Fauser BC. Ovarian aging: mechanisms and clinical consequences. Endocr Rev 2009;30:465-493.
3. Broer SL, Dólleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update 2011;17:46-54.
4. Broer SL, van Disseldorp J, Broeze KA, Dolleman M, Opmeer BC, Bossuyt P, Eijkemans MJ, MolBW, Broekmans FJ, IMPORT study group. Added value of ovarian reserve testing on patient characteristics in the prediction of ovarian response and ongoing pregnancy: an individual patient data approach. Hum Reprod Update 2013;19:26-36.
5. Cagnacci A, Pansini FS, Bacchi-Modena A, Giulini N, Mollica G,DeAloysio D, Vadora E, Volpe A. Seasonal onset of the menopause. Emilia-Romagna Operative Group for Menopause (GOERM). Maturitas 2005;51: 393-396.
6. De Boer EJ, den Tonkelaar I, te Velde ER, Burger CW, van Leeuwen FE; OMEGA-project group. Increased risk of early menopausal transition and natural menopause after poor response at first IVF treatment. Hum Reprod 2003;18:1544-1552.
7. De VosM, Devroey P, Fauser BC. Primary ovarian insufficiency. Lancet 2010; 376:911-921.
8. Dólleman M, Verschuren WM, Eijkemans MJ, Dollé ME, Jansen EH, Broekmans FJ, van der Schouw YT. Reproductive and lifestyle determinants of anti-Müllerian hormone in a large population-based study. J Clin Endocrinol Metab 2013;98:2106-2115.
9. Dólleman M, Depmann M, Eijkemans MJ, Heimensem J, Broer SL, van der Stroom EM, Laven JS, Van Rooij IA, Scheffer GJ, Peeters PH et al. Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause. Hum Reprod 2014; 29:584-591.
10. Dossus L, Allen N, Kaaks R, Bakken K, Lund E, Tjonneland A, Olsen A, Overvad K, Clavel-Chapelon F, Fournier A et al. Reproductive risk factors and endometrial cancer: the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2010;127:442-451.
11. Faddy MJ, Gosden RG. Amodel conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 1996;11:1484-1486.
12. Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L; ESHRE working group on Poor Ovarian Response Definition. ESHRE consensus on the definition of 'poor response' to ovarian stimulation for in vitro fertilization: the Bologna criteria.HumReprod 2011;26:1616-1624.
13. Fleming R, KelseyTW, Anderson RA,WallaceWH,Nelson SM. Interpreting human follicular recruitment and antimüllerian hormone concentrations throughout life. Fertil Steril 2012;98:1097-1102.
14. Francucci CM, Ceccoli L, Caudarella R, Rilli S, Boscaro M. Skeletal effect of natural early menopause. J Endocrinol Invest 2010;33:39-44.
15. Freeman EW, SammelMD,Lin H, BoormanDW, Gracia CR. Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women. Fertil Steril 2012a; 98:1254-1259.
16. Freeman EW, Sammel MD, Lin H, Gracia CR. Anti-mullerian hormone as a predictor of time to menopause in late reproductive age women. J Clin Endocrinol Metab 2012b;97:1673-1680.
17. Gleicher N, Weghofer A, Barad DH. Discordances between follicle stimulating hormone (FSH) and anti-Müllerian hormone (AMH) in female infertility. Reprod Biol Endocrinol 2010;8:64.
18. Gougeon A. Dynamics of follicular growth in the human: a model from preliminary results. Hum Reprod 1986;1:81-87.
19. Gougeon A. Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas 1998;30:137-142.
20. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 2008;23:699-708.
21. Hansen KR, Hodnett GM, Knowlton N, Craig LB. Correlation of ovarian reserve tests with histologically determined primordial follicle number. Fertil Steril 2011;95:170-175.
22. Hilbe JM. Negative Binomial Regression, 2nd Edition, 2011, Cambridge, UK: Cambridge University Press. Iliodromiti S, Nelson SM. Biomarkers of ovarian reserve. Biomark Med 2013; 7:147-158.
23. La Marca A, Sighinolfi G, Radi D, Argento C, Baraldi E, Artenisio AC, Stabile G, Volpe A. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010a;16:113-130.
24. La Marca A, Sighinolfi G, Giulini S, Traglia M, Argento C, Sala C, Masciullo C, Volpe A, Toniolo D. Normal serum concentrations of anti-Müllerian hormone in women with regular menstrual cycles. Reprod Biomed Online 2010b;21:463-469.
25. La Marca A, Spada E, Sighinolfi G, Argento C, Tirelli A, Giulini S, Milani S, Volpe A. Age-specific nomogram for the decline in antral follicle count throughout the reproductive period. Fertil Steril 2011;95:684-688.
26. La Marca A, Argento C, Sighinolfi G, Grisendi V, Carbone M, D'Ippolito G, Artenisio AC, Stabile G, Volpe A. Possibilities and limits of ovarian reserve testing in ART. Curr Pharm Biotechnol 2012;13:398-408.
27. La Marca A, Sighinolfi G, Papaleo E, Cagnacci A, Volpe A, Faddy MJ. Prediction of age at menopause from assessment of ovarian reserve may be improved by using body mass index and smoking status. PLoS One 2013a;8:e57005.
28. La Marca A, Grisendi V, Giulini S, Argento C, Tirelli A, Dondi G, Papaleo E, Volpe A. Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count. J Ovarian Res 2013b;6:11-18.
29. Lawson R, El-Toukhy T, Kassab A, Taylor A, Braude P, Parsons J, Seed P. Poor response to ovulation induction is a stronger predictor of early menopause than elevated basal FSH: a life table analysis. HumReprod 2003;18:527-533.
30. Nelson SM. Antimüllerian hormone: is the writing on the wall for antral follicle count? Fertil Steril 2013;99:1563-1564.
31. Oktay K, Kim JY, Barad D, Babayev SN. Association ofBRCA1mutations with occult primary ovarian insufficiency: a possible explanation for the link between infertility and breast/ovarian cancer risks. J Clin Oncol 2010; 28:240-244.
32. Parazzini F; Progetto Menopausa Italia Study Group. Determinants of age at menopause inwomenattending menopause clinics in Italy. Maturitas 2007; 56:280-287.
33. Parsa P, Parsa B. Effects of reproductive factors on risk of breast cancer: a literature review. Asian Pac J Cancer Prev 2009;10:545-550.
34. Ramezani Tehrani F, Dólleman M, van Disseldorp J, Broer SL, Azizi F, Solaymani-Dodaran M, Fauser BC, Laven JS, Eijkemans MJ, Broekmans F. Predicting menopausal age with anti-Müllerian hormone: a crossvalidation study of two existing models. Climacteric 2014;1-8. (epub ahead of print).
35. Rocca WA, Grossardt BR, Shuster LT. Oophorectomy, menopause, estrogen, and cognitive aging: the timing hypothesis. Neurodegener Dis 2010;7:163-166.
36. Rödström K, Bengtsson C, Milsom I, Lissner L, Sundh V, Bjoürkelund C. Evidence for a secular trend in menopausal age: a population study of women in Gothenburg. Menopause 2003;10:538-543.
37. Rosen MP, Johnstone E, Addauan-Andersen C, Cedars MI. A lower antral follicle count is associated with infertility. Fertil Steril 2011;95:1950-1954.
38. Shuster LT, Rhodes DJ, Gostout BS, Grossardt BR, RoccaWA. Premature menopause or early menopause: long-term health consequences. Maturitas 2010;65:161-166.
39. te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update 2002;8:141-154.
40. Tehrani FR, Solaymani-Dodaran M, Tohidi M, Gohari MR, Azizi F. Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab 2013;98:729-735.
41. van Disseldorp J, Faddy MJ, Themmen AP, de Jong FH, Peeters PH, van der Schouw YT, Broekmans FJ. Relationship of serum antimüllerian hormone concentration to age at menopause. J Clin Endocrinol Metab 2008;93:2129-2134.
42. Wallace WH, Kelsey TW. Human ovarian reserve from conception to the menopause. PLoS One 2010;27:5.
43. Wellons MF, Bates GW, Schreiner PJ, Siscovick DS, Sternfeld B, Lewis CE. Antral follicle count predicts natural menopause in a population-based sample: the Coronary Artery Risk Development in Young Adults Women's Study. Menopause 2013;20:825-830.